Treatment of Adult Men with High-risk Biochemical Recurrent Non-metastatic Hormone-sensitive Prostate Cancer as Monotherapy or in Combination with Androgen Deprivation Therapy, Who Are Unsuitable for Salvage Radiotherapy
40mg
Blocks androgen receptors and inhibits androgen receptor signalling to slow prostate cancer growth and delay disease progression in adult men with prostate cancer.
Related medicines appear within Prostate Health.
Information about Enzalutamide on this page is an educational overview, not medical advice. Products can differ in formulation, strength, and directions, and this content does not authorise clinical application or unsupervised use. Review the labelling for each product and speak with a healthcare professional whenever clinical judgement is needed. Product-specific contraindications, interactions, and reactions should be checked in the product labelling and verified clinical sources.
